Peripheral neuropathy caused by chemotherapy with" Taxane" drugs.
Conditions
Interventions
Intervention 1: Intervention group: Breast cancer patients with a history of chemotherapy with "Taxanes", who have symptoms of peripheral neuropathy based on neurological examination and diagnosis and
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: patient is undergoing chemotherapy or has a history of chemotherapy with" Taxanes" at most in the last 2 months Based on the expert's diagnosis, patient has grade B peripheral neuropathy caused by ;chemotherapy based on the PNQ questionnaire;
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Peripheral neuropathy symptoms based on PNQ questionnaire. Timepoint: Measurement of peripheral neuropathy symptoms based on PNQ questionnaire 1 month after drug use. Method of measurement: PNQ questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactOmid Khaleghpanah
Shahid Beheshti University of Medical Sciences
Outcome results
None listed